Transforming Healthcare Delivery: Point of Care Molecular Diagnostics Market Forecast
Point of Care Molecular Diagnostics Market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 10.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics, increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127 The Assays & Kits segment is expected to account for the largest share of the Point of Care Molecular Diagnostics Market in 2022. The products & services in the point-of-care molecular diagnostics market are categorized into assays & kits, instruments & analyzers, and software & services. Assays & kits specifica...